A newly proposed International Association for the Study of Lung Cancer (IASLC) tumor budding–based grading system ...

Patients in CONVERGE have stage 3 lung cancer and receive chemotherapy and radiation at the same time, followed by the immunotherapy Imfinzi (durvalumab) given by IV. Even with that treatment, fully ...

Daraxonrasib (Rasonque), recently approved for the treatment of metastatic pancreatic cancer, is also showing promise in the ...

Three new studies from WCLC 2026 show strong results in ROS1-positive NSCLC, EGFR-mutant NSCLC and relapsed small cell lung ...

AI pathology tool measures lung cancer treatment response after neoadjuvant chemoimmunotherapy with 91% accuracy, speeding NSCLC care while needing review for complete response. An artificial ...

The findings were published in the Proceedings of the National Academy of Sciences.

Nanobiotix S.A. (NASDAQ:NBTX) reported September 14 results from all 24 patients in the dose-escalation and expansion portions of a Phase 1 study of JNJ-1900, also called NBTXR3, combined with repeat ...

An AI system called iSeg is reshaping radiation oncology by automatically outlining lung tumors in 3D as they shift with each breath. Trained on scans from nine hospitals, the tool matched expert ...

Detecting lung cancer early is critical to a patient's survival, but how early is early enough? Florida International ...

For years, researchers have known that, among people diagnosed with lung cancer, the prevalence of nonsmokers has been increasing. But they have been trying to determine what factors — whether genetic ...

By Nancy Lapid Sept 15 (Reuters) - Hello Health Rounds readers! Today we highlight a potentially game-changing experimental contrast agent for MRI exams that may enable detection of lung cancer when ...

Up to twenty percent of lung cancer cases in the United States strike people who never smoked. Scientists have long suspected ...